Genetic analysis has led to the delineation of two NF-κB-like signaling pathways, the immune deficiency (imd) and the Toll pathways, which control the expression of genes encoding the AMPs via activation of distinct NF-κB transcription factors. This evidence concerns the gene NFKB1 and Immunodeficiency.